［1］ Shah NM，Scott DM，Kandagatla P，et al.Young women with breast cancer:Fertility preservation options and management of pregnancy-associated breast cancer［J］.Ann Surg Oncol，2019,26(5):1214-1224.
［2］ Loibl S，Schmidt A，Gentilini O，et al.Breast cancer diagnosed during pregnancy：Adapting recent advances in breast cancer care for pregnant patients［J］.JAMA Oncol，2015,1(8):1145-1153.
［3］ Johansson ALV，Andersson TM，Hsieh CC，et al.Tumor characteristics and prognosis in women with pregnancy-associated breast cancer［J］.Int J Cancer,2018,142(7):1343-1354.
［4］ Hartman EK，Eslick GD.The prognosis of women diagnosed with breast cancer before，during，and after pregnancy:A Meta analysis［J］.Breast Cancer Res Treat,2016,60(2):347-360.
［5］ Gradishar WJ，Anderson BO，Balassanian R,et al.Invasive breast cancer version 1.2016，NCCN clinical practice guidelines in oncology［J］.Journal of the National Comprehensive Cancer Network Jnccn，2016，14(3):324-354.
［6］ Al-Amri A.Clinical presentation and causes of the delayed diagnosis of breast cancer in patients with pregnancy associated breast cancer［J］.J Family Community Med,2015，22(2):96-100.
［7］ Carmichael H，Matsen C，Freer P，et al.Breast cancer screening of pregnant and breastfeeding women with BRCA mutations［J］.Breast Cancer Res Treat,2017,162(2):225-230.
［8］ Vashi R，Hooley R，Butler R，et al.Breast imaging of the pregnant and lactating patient：Imaging modalities and pregnancy-associated breast cancer［J］.Am J Roentgenol，2013,200(2):321-328.
［9］ Whitworth M，Bricker L，Mullan C.Ultrasound for fetal assessment in early pregnancy［J］.Cochrane Database of Systematic Reviews，2015，14(7):7-58.
［10］ Paluch-Shimon S，Pagani O，Partridge AH，et al.ESO-ESMO 3rd international consensus guidelines for breast cancer in young women（BCY3)［J］.The Breast，2017(35):203-217.
［11］ Diflorio-Alexander RM，Slanetz PJ，Moy L，et al.ACR appropriateness criteria breast Imaging of pregnant and lactating women［J］.Journal of the American College of Radiology，2018，15(11):263-275.
［12］ Peccatori FA，Codacci-Pisanelli G，Del Grande M，et al.Whole-body MRI for systemic staging ofbreast cancer in pregnant women［J］.Breast，2017(35):177-181.
［13］ Zanotti-Fregonara P，Laforest R，Wallis JW.Fetal radiation dosefrom 18F-FDG in pregnant patients imaged with PET，PET/CT,and PET/MR［J］.J Nucl Med,2015,56(8):1218-1222.
［14］ Amant F，von Minckwitz G，Han SN，et al.Prognosis of women with primary breast cancer diagnosed during pregnancy：Results from an international collaborative study［J］.J Clin Oncol,2013,31(20):2532-2539.
［15］ Triunfo S，Scambia G.Cancer in pregnancy:Diagnosis，treatment and neonatal outcome［J］.Minerva Ginecologica，2014，66(3):325-334.
［16］ Committee on Obstetric Practice and the American Society of Anesthesiologists.Committee opinion No.696：Nonobstetric surgery during pregnancy［J］.Obstetrics & Gynecology，2017，129(4):777-778.
［17］ Johansson ALV,Andersson ML，Hsieh CC，et al.Stage at diagnosis and mortality in women with pregnancy-associated breast cancer（PABC)［J］.Breast Cancer Research & Treatment，2013,139(1):183-192.
［18］ Peccatori FA，Lambertini M，Scarfone G，et al.Biology，staging，and treatment of breast cancer during pregnancy：Reassessing the evidences［J］.Cancer Biology & Medicine，2018，15(1):6-13.
［19］ Caragacianu DL，Mayer EL，Chun YS，et al.Immediate breast reconstruction following mastectomy in pregnant women with breast cancer［J］.J Surg Oncol,2016,114(2):140-143.
［20］ Lohsiriwat V，Peccatori FA，Martella S，et al.Immediate breast reconstruction with expander in pregnant breast cancer patients［J］.Breast,2013,22(5):657-660.
［21］ Bleker SM，Buchmüller Andrea，Chauleur Céline，et al.Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy：Rationale and design of the Highlow study，a randomised trial of two doses［J］.Thrombosis Research，2016(144):62-68.
［22］ Krag D，Anderson S，Julian T，et al.Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer：Overall survival findings from the NSABP B-32 randomised phase 3 trial［J］.Lancet Oncol 2010,11(10):927-933.
［23］ Hank SN，Amant F，Cardonick EH，et al.Axillary staging for breast cancer during pregnancy:Feasibility and safety of sentinel lymph node biopsy［J］.Breast Cancer Res Treat,2018,168(2):551-557.
［24］ Shlensky V，Hallmeyer S，Juarez L，et al.Management of breast cancer during pregnancy：Are we compliant with current guidelines［J］? AJP Rep,2017，7(1):e39-e43.
［25］ Gropper AB，Calvillo KZ，Dominici L，et al.Sentinel lymph node biopsy in pregnant women with breast cancer［J］.Ann Surg Oncol,2014,21(8):2506-2511.
［26］ Keyser EA，Staat BC，Fausett MB，et al.Pregnancy-associated breast cancer［J］.Rev Obstet Gynecol,2012(5):94-99.
［27］ Mcgee SF，Mazzarello S，Caudrelier JM，et al.Optimal sequence of adjuvant endocrine and radiation therapy in early-stage breast cancer-A systematic review［J］.Cancer Treatment Reviews，2018(69):132-142.
［28］ Program NT.NTP monograph：Developmental effects and pregnancy outcomes associated with cancer chemotherapy use during pregnancy［J］.Ntp Monograph，2013(2):214.
［29］ Cardonick E，Dougherty R，Grana G，et al.Breast cancer during pregnancy：Maternal and fetal outcomes［J］.Cancer J,2012,23(12):3016-3023.
［30］ Loibl S，Han SN，von Minckwitz G，et al.Treatment of breast cancer during pregnancy:An observational study［J］.Lancet Oncol,2012,13(9):887-896.
［31］ Zagouri F，Sergentanis TN，Chrysikos D，et al.Taxanes for breast cancer during pregnancy:A systematic review［J］.Clin Breast Cancer,2013,13(1):16-23.
［32］ Peccatori FA，Azim HA，Orecchia R，et al.Cancer，pregnancy，and fertility：ESMO clinical practice guidelines for diagnosis，treatment and follow-up［J］.Ann Oncol,2013,24(Suppl 6):vi160-170.
［33］ Amant F，Halaska MJ，Fumagalli M，et al.Gynecologic cancers in pregnancy:Guidelines of a second international consensus meeting［J］.Int J Gynecol Cancer，2014,24(3)：394-403.
［34］ Boxer L，Bolvard A，Kelley M，et al.Use of granulocyte colony-stimulating factor during pregnancy in women with chronic neutropenia［J］.Obstet Gynecol，2015,125(1):192-203.
［35］ Braems G，Denys H，De Wever O,et al.Use of tamoxifen before and during pregnancy［J］.Oncologist,2011(16):1547-1551.
［36］ Lambertini M，Peccatori FA，Azim HA.Targeted agents for cancer treatment during pregnancy［J］.Cancer Treat Rev,2015,41(4):301-309.
［37］ Maly JJ，Macrae ER.Pertuzumab in combination with trastuzumab and chemotherapy in the treatment of HER2-positive metastatic breast cancer:Safety，efficacy，and progression-free survival［J］.Breast Cancer Auckl,2014,12(8):81-88.
［38］ Wang B，Yang Y，Jiang Z,et al.Clinicopathological characteristics，diagnosis，and prognosis of pregnancy-associated breast cancer［J］.Thorac Cancer，2019，28(10)：1759-1774.
［39］ Nettleton J，Long J，Kuban D，et al.Breast cancer during pregnancy：Quantifying the risk of treatment delay［J］.Obstet Gynecol，1996,87(3):414-418.
［40］ Beadle BM，Woodward WA，Middleton LP，et al.The impact of pregnancy on breast cancer outcomes in women≤35 years［J］.Cancer，2009,115(6):1174-1184.